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Abstract
Objectives: Most cases of pleural empyema are caused by pulmonary infections, which are usually combined with
pneumonia or lung abscess. The mortality of patients with pleural empyema remains high (up to 20%). It also
contributes to higher hospital costs and longer hospital stays. We studied pleural empyema with combined lung
abscess to determine if abscess was associated with mortality.
Methods: From January 2004 to December 2006, we retrospectively reviewed 259 patients diagnosed with pleural
empyema who received thoracscopic decortications of the pleura in a single medical center. We evaluated their
clinical data and analyzed their chest computed tomography scans. Outcomes of pleural empyema were
compared between groups with and without lung abscess.
Results: Twenty-two pleural empyema patients had lung abscesses. Clinical data showed significantly higher
incidences in the lung abscess group of pre-operative leukocytosis, need for an intensive care unit stay and
mortality.
Conclusion: Patients with pleural empyema and lung abscess have higher intensive care unit admission rate,
higher mortality during 30 days and overall mortality than patients with pleural empyema. The odds ratio of lung
abscess is 4.685. Physician shall pay more attention on high risk patient of lung abscess for early detection and
management.
Background
Pleural empyema is one of the serious complications of
pneumonia, and increases the morbidity and mortality
due to pneumonia [1-3]. About 5% of patients with
pneumonia suffer from pleural empyema [4,5]. About
65,000 patients in the United State and the United King-
dom suffer annually from pleural empyema or a compli-
cated parapneumonic effusion. The mortality of patients
with pleural empyema is up to 20% and contributes to
higher hospital costs. Inflammatory mechanisms and
alterations in the balance of pleural fibrinolysis have
been implicated in the pathophysiology of infectious
pleural effusion. Pleural empyema is associated with
fibrin deposition over pleural surfaces due to inhibition
of the fibrinolysis system [6,7]. Parapneumonic effusions
progress through exudative and fibrinopurulent stages
and terminate in empyema in the organized stage. The
clinical courses of patients with parapneumonic effu-
sions or pleural empyema are varied. Lung abscess is
defined as a circumscribed collection of pus in the lung,
which leads to formation of a cavity. It develops when a
localized area of parenchymal infection becomes necro-
tic and then cavitates. It most commonly occurs second-
ary to aspiration in patients with poor dentition or as a
complication of necrotizing pneumonia. Lung abscess
has previously been thought to be a rare condition of
empyema and parapneumonic effusions. About 90% of
patients with lung abscesses been cured by antibiotics
therapies simply [8]. Surgical resection of lung abscess is
rare when medical treatments fail.
Pleural empyema and lung abscess are both a part of
low respiratory tract infection. According to the clinical
observation, pleural empyema and lung abscesses may
happen on the same patient. However, the strategies of
these two diseases are so different. It is interesting
whether the surgical results are the same of empyema
patients with and without lung abscesses. We compared
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with pleural empyema with and without lung abscesses.
Methods
Patients
This was a retrospective cohort study conducted in eva-
luation the impact of lung abscess on the surgical results
of patients with pleural empyema. From January 2004 to
December 2006, 259 patients were diagnosed with
pleural empyema and received thoracoscopic decortica-
tion of pleural in Changhua Christian Hospital in central
Taiwan. The diagnosis for all the patients was based
initially on a chest X-ray followed by a computed tomo-
graphy (CT) scan or ultrasound. All of the operations
were performed by one of four qualified thoracic sur-
geons in our hospital. Pleural empyema was classified
according to the American Thoracic Society staging;
stage I is exudative pleuresia, stage II is fibrinopurulent
and stage III is organized. Thoracentesis was performed
on these patients for a sample of pleural fluid to deter-
mine pH, lactate dehydrogenase, glucose, protein levels,
and blood cell count. After the diagnosis was estab-
lished, all the patients were treated with an appropriate
antibiotic therapy. The patients, who were classified into
phase II or phase III pleural empyema received video-
assist thoracoscopic surgery (VATS) for decortications
of pleura. The operation was converted to open thora-
cotomy if it was failed by VATS. The patients with
pleural empyema and lung abscess received VATS dec-
ortications only. We recorded the following clinical data:
age, gender, and clinical findings; chronology of initial
signs and diagnoses; bacteriological and biochemical stu-
dies of pleural fluids; and radiological and pre-operative
findings. The vital signs were recorded just before
operation in the operation room. Lung abscess was
defined as a circumscribed collection of pus in the lung
that led to cavity formation, which was noted on chest
radiograph, CT scan or intraoperative findings by the
surgeon. In our study, there was no any patient in lung
abscess group received additional chest tube insertion or
abscess aspiration before or after operation. Figure 1
shows an example of chest radiograph and CT scan for
loculated pleural fluid collection and Figure 2 is an
example of chest radiograph and CT scan of pleural
empyema accompanied by abscess. Leukocytosis was
defined as a white blood cell count > 10,000/μL (refer-
ence value in Changhua Christian Hospital). The out-
come measures were post-operative complications and
the length of hospitalization.
Surgical procedures
All patients were transferred to the operating room and
underwent general anesthesia with double-lumen endo-
tracheal tube or single lumen endotracheal tube
intubation. A patient was placed in the true lateral decu-
bitus position on the side opposite to the empyema.
Two ports were used (telescope and one instrument)
after selective one lung ventilation or apnea. The wound
was enlarged when the thoracoscopic procedure was dif-
ficult to perform. After a systematic sampling of fluid,
abundant irrigation and aspiration were performed.
Extensive debridement and ablation of all septa allowed
t h ee n t i r ep l e u r a lc a v i t yt obe unified. Removal of the
visceral and parietal pleural peel was by VATS as com-
plete as possible, with attention paid to the visceral
pleura in order to avoid air leakage. The lung re-expan-
sion after decortication was confirmed during operation
by two lung ventilation. If failure, mini-thoracotomy was
performed for adequate decortication until full expan-
sion of the lung was confirmed. Two chest tubes (28 or
32 Fr) were positioned to the anterior and posterior.
After the operation, the chest tube was connected to
Figure 1 The chest radiograph and computed tomography
scan showed pleural empyema without lung abscess.
Figure 2 The chest radiograph and computed tomography
showed pleural empyema with lung abscess.
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cm H2O using an Emerson postoperative suction pump)
regularly.
Statistical methods
Data are presented as median medians ± standard error
for continuous variables and number (percentage) for
categorical variables. Continuous and categorical vari-
ables were statistically compared by Mann-Whitney U
test and Fisher’s exact test. Survival curves were gener-
ated using the Kaplan-Meier method and differences
were determined using the log-rank test. A two-tailed P-
value of ≤ 0.05 was considered significant.
Results
There were 259 patients who had pleural empyema
from January 2004 to December 2006 who underwent
surgical interventions during the investigation period.
There were 202 (78%) men and 57 (22%) women. Nine-
teen patients died during the same admission. The sur-
gical mortality rate was 7.3% (19 of 259). All early and
late deaths were attributed to progressive uncontrolled
sepsis.
The causes of pleural empyema included low respira-
tory infection (n = 239, 92%), lung cancer (n = 9, 3.5%),
induced by deep neck infection (n = 1, 0.39%), post-
traumatic empyema (n = 6, 2.3%) and post-operative
complication (n = 4, 1.5%). Two patients were converted
to mini-thoracotomy (2 of 259, 0.77%). In abscess group,
there were nineteen phase II patients and three phase III
patients. In non-abscess group, there were six phase I
patients, two hundred and seven phase II patients and
three phase III patients. There was no significant differ-
ent between the two groups (P = 0.052).
Bacteria culture were performed for the 259 patients
during their operations and microorganism growth was
detected in 86 sets (86 of 259, 33%). There were 161
patients who had bacterial blood cultures and 25 posi-
tive results (16%); 173 patients had bacterial cultures of
pleural effusion before surgery and only 42 positive
results (24%).
The mean hospital stay was 24.8 ± 31.7 days and the
mean post-operative hospital stay was 17.5 ± 27.8 days
in all patients. The mean period of pre-operative anti-
biotic therapy in the mortality group was 13.0 ± 11.5
days. The mean period of pre-operative antibiotic ther-
apy in the surviving group was 7.6 ± 9.8 days. There
was a significant different between the two groups (P =
0.037). There were no significant differences in clinical
presentations, such as heart rate, body temperature,
mean arterial pressure, respiratory rates or co-morbid-
ities (Table 1).
There were 22 patients with lung abscesses based on
image studies or by the findings during surgery. Pre-
operative leukocytosis (P = 0.002), need for intensive
care unit stays (P = 0.032), 30 days mortality (P = 0.003;
Table 1 Characteristics of pleural empyema patients with and without lung abscess
Lung abscess
(N = 22)
Non- lung abscess
(N = 237)
P-value
Age (year) 51.9 ± 25.0 57.8 ± 18.4 P = 0.298
Gender
Male 18 184 P = 0.792
Female 4 53
Diabetes mellitus 5 71 P = 0.476
Cerebrovascular accident 4 26 P = 0.299
Hypertension 5 76 P = 0.366
Tuberculosis 1 25 P = 0.371
Chronic obstructive pulmonary disease 1 11 P = 1.000
Peptic ulcer 2 17 P = 0.669
Asthma 1 3 P = 0.300
Lung cancer 0 9 P = 1.000
Other malignancy 2 16 P = 0.656
Leukocytosis (WBC > 10000/mm
3) 21 150 P = 0.002*
Heart rate (/min) 96.3 ± 18.8 94.5 ± 16.5 P = 0.418
Mean arterial pressure (mmHg) 93.1 ± 10.8 96.9 ± 14.0 P = 0.211
Body temperature (°C) 37.0 ± 0.8 37.1 ± 2.1 P = 0.947
Respiratory rate (/min) 23.0 ± 6.5 21.6 ± 5.2 P = 0.233
1. Values are medians ± standard error for continuous variables or # cases for categorical variables.
2. P-values from Mann-Whitney U test (continuous variables) or Fisher exact test (categorical variables).
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Figure 3, lower panel) were significantly different
between the abscess group and the no abscess group
(Table 2). Patients with lung abscess formation might
require additional surgical procedures for residual
empyema (P = 0.081).
14 patients were cared in intensive care unit before
operation due to respiratory failure or unstable vital
signs. In abscess group, there was only one patient
cared in intensive care unit. In non-abscess group, there
were 13 patients cared in intensive care unit. Excluding
patients cared in intensive care unit (ICU) before opera-
tion, the patient cared in ICU after operation is 13 in
abscess group and 81 in non-abscess group. The rate of
admission to ICU after operation had significant differ-
ent between the groups (P = 0.023).
The data of alcohol use of 194 patients were available.
It was collected from patient himself, nurse record and
medical chart. There were 24 patients use alcohol some-
times and 3 patients had abscess formations. 14 patients
used alcohol everyday but no one had abscess forma-
tion. By the available data, the patient number of alcohol
use or alcohol abuse had no significant difference
between the abscess and non-abscess group (P = 0.625).
There was also no significant difference between the
mortality and survive group (P = 0.557).
Discussions
About 20% of cases of paraneumonic effusion progress
to pleural empyema despite the effective antibiotics and
drainage of pleural effusion [3]. Early diagnosis and
prompt drainage of pleural space infections are crucial,
as delay increases morbidity. Pleural empyema can
occur as a complication of pneumonia, tuberculosis or
surgical procedures. In our study, the majority of our
cases resulted from respiratory tract infection, as the
same as other reports. An appropriate treatment for
pleural empyema will include sepsis control, restoration
of pulmonary function and prevent lung entrapment
after the fibrous peel [9,10].
A lung abscess is a thick-walled cavity that contains
purulent material and can occur at any age [11]. About
ninety percent of patients with lung abscesses were
cured by simply antibiotics therapy [8,12]. It is rarely
necessary to resect the lung abscesses. The role of sur-
gery for lung abscess is to manage the complications,
including pleural empyema and bronchopleural fistula.
Some patients had pleural empyema and lung abscess at
the same time. In this study, the patient characteristics
showed no significant differences between the two
groups such as co-morbidity and clinical presentation,
but leukocytosis. There were more patients with leuko-
cytosis in lung abscess group. There were 21 (96%)
patients with leukocytosis in the abscess group. Only
150 (63%) patients had leukocytosis of the patients in
the no abscess group. However, leukocytosis may be
related to inflammation or infection, but the number of
white cell counts does not reflect the severity of inflam-
mation or infection. Although the difference between
the two group has statistical significant (P = 0.002), it is
rough to conclude the diagnosis and severity according
to the white cell count.
The leading cause of pleural empyema in our study
was low respiratory tract infection and the incidence
was 93%, and 22 of these patients (8.5%) had abscesses.
Previous studies also identified bronchopulmonary infec-
tion as an important cause of empyema [13]. Lung
Figure 3 Survival curves after surgery. The survival curves used
the Kaplan-Meier method and differences were calculated using the
log-rank test. Upper panel: The 30 days survival shows a significant
difference (P = 0.003). Lower panel: The overall post-operative
survival between the 2 groups also shows a significant difference (P
= 0.004).
Huang et al. Journal of Cardiothoracic Surgery 2010, 5:88
http://www.cardiothoracicsurgery.org/content/5/1/88
Page 4 of 6malignancy, post-trauma, post-operative complications
and deep neck infection were the other causes of pleural
empyema in our study. Our study showed less post-
traumatic pleural empyema rate than previous study.
The low incidence may be due to early chest tube drai-
nage when traumatic patients had related pleural effu-
sion in our department [14].
Lung abscess have been associated with alcohol abuse.
However, in our study, the patient number of alcohol
use or alcohol abuse had no significant difference
between the abscess and non-abscess group (P = 0.625).
There was also no significant difference between the
mortality and survive group (P = 0.557). However, the
data was limited by the patient number of abscess
group, the accuracy of medical record and nurse record,
as well as the different definition of alcohol use and
alcohol abuse.
The mean periods of pre-operative antibiotic therapy
in the mortality group was longer than in the surviving
group, respectively (P = 0.037). According to these
results, early surgery after diagnosis appears to decrease
the mortality. Some studies showed that early decortica-
tion of the pleura by VATS was a safe, curative treat-
ment of pleural empyema with low morbidity [15,16].
However, some patients in our study were admitted for
other diseases or were given antibiotics for other infec-
tion sources before pleural empyema was diagnosed.
Longer antibiotics period may be due to poor infection
control or nosocomial infection. The delay or increase
duration of preoperative antibiotics may result from
delaying diagnosis of empyema or lung abscess. There
are many patients with low respiratory infection compli-
cated with pleural empyema. The diagnosis shall be kept
in mind. According to Coote et al and Petrakis et al,
once pleural empyema is diagnosed, early and adequate
drainage as well as early operation, especially the less
invasive operation, VATS, is helpful to patient [17,18].
Bacterial cultures of the pleural empyema were per-
formed in all patients. However, there were only 33%
positive results from all these cultures. There were 161
patients who had bacterial blood cultures and only 25
(16%) positive results; 173 patients had bacterial cultures
of pleural effusions before surgery and only 42 (24%)
positive results. There was no significant difference for
mortality based on the results of bacterial cultures. Echo
guidance aspiration for pleural effusion is helpful to dis-
tinguish the quality of pleural effusion which is a guide
of management. As Nyambat et al suggested in 2008,
due to the low culture rate, culture may not be a suffi-
ciently sensitive diagnostic method to determine the
etiology in the majority of cases. The cost-effectiveness
of pre-operative pleural effusion culture or blood culture
shall be discussed after further study.
T h ea b s c e s sg r o u pa l s os h o w e dah i g h e rf r e q u e n c yt o
enter the ICU after surgery (P = 0.032). After excluding
the patients in ICU before operation (one in abscess
group and thirteen in no abscess group), the frequency
to enter the ICU after surgery still has significant differ-
ence (P = 0.023). The indications for admission to an
ICU were unstable vital signs, unstable respiratory pat-
terns and previous ICU stays. The result revealed that
the patients with pleural empyema and lung abscess
were more critical.
However, there was no statistical difference in the
length of ICU stays, lengths of admission or length of
post-operative stays. This may have been due to the
large capacity of the respiratory care center or respira-
tory care ward. All the patients could be transferred to
these units after sepsis or bronchopulmonary infections
were controlled, and then transferred to a nursing home
if conditions became stable and necessary. It also may
be due to the failure to calculate the length of stay in
other hospital before transferring to our hospital. In our
study, the length of stay for patients in pleural empyema
was 24.8 days and the length of stay after surgery was
17.5 days. The length of stay was longer than previous
data. This may resulted from co-morbidity, delayed
diagnosis of pleural empyema or a delay in surgical
intervention. Some studies showed that early surgical
intervention was the most optimal and cost-effective
initial modality for the treatment of empyema [19].
Five (23%) patients died after their operations in the
abscess group within 30 days of surgery or during the
same admission. The mortality rate of the no abscess
group was only 5.9%, consistent with overall mortalities
observed in previous series studies [13,19,20]. Patients
Table 2 Outcomes of pleural empyema patients with and without lung abscess
Lung abscess
(N = 22)
Non-lung abscess
(N = 237)
P-value
Intensive care unit admission 14(64%) 95(40%) P = 0.032*
Length of hospital stay (days) 24.9 ± 32.8 24.8 ± 16.6 P = 0.992
Post-operation length of hospital stay (days) 17.3 ± 28.9 17.5 ± 11.0 P = 0.978
Mortality 5(23%) 14(6%) P = 0.004*
1. Values are medians ± standard error for continuous variables or # cases (%) for categorical variables.
2. P-values from Mann-Whitney U test (continuous variables) or Fisher exact test (categorical variables).
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without lung abscess (P = 0.004). The Odds ratio for
lung abscess was 4.69 (95% confidence interval = 1.057-
14.56). Furthermore, patients in the abscess group also
had a trend to receive second decortications of the
pleura (P = 0.081). The multiple logistic regressions
revealed lung abscess was not an independent predictor
of death. Why the lung abscess group required further
procedures? According to our data, it may be due to
worse condition of the lung abscess group. The operator
may stopped the operation before the completely
removal of the peel due to unstable vital signs during
operation. Bronchopleural fistula may also play a role in
such a situation; however we had only a little experience
with bronchopleural fistula. The overall mortality was
higher in the abscess group, too.
Conclusion
Patients with pleural empyema and lung abscess have
higher ICU admission rate, higher mortality during 30
days and overall mortality than patients with pleural
empyema. The Odds ratio of lung abscess is 4.685. Phy-
sician shall pay more attention on high risk patient of
lung abscess for early detection and management.
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